These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33314508)

  • 1. Repeated CD45RA-depleted DLI successfully increases donor chimerism in a patient with beta-thalassemia major after haploidentical stem cell transplant.
    Chan WYK; Kwok JSY; Chiang AKS; Chan GCF; Lee PPW; Ha SY; Cheuk DKL
    Pediatr Transplant; 2021 Aug; 25(5):e13945. PubMed ID: 33314508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
    Brodszki N; Turkiewicz D; Toporski J; Truedsson L; Dykes J
    Orphanet J Rare Dis; 2016 Jan; 11():5. PubMed ID: 26768987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive Repopulation and Allo-Immunologic Pressure Determine Chimerism Kinetics after T Cell-Depleted Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion.
    Koster EAS; von dem Borne PA; van Balen P; van Egmond EHM; Marijt EWA; Veld SAJ; Jedema I; Snijders TJF; van Lammeren D; Veelken H; Falkenburg JHF; de Wreede LC; Halkes CJM
    Transplant Cell Ther; 2023 Apr; 29(4):268.e1-268.e10. PubMed ID: 36587743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation.
    Koster EAS; von dem Borne PA; van Balen P; Marijt EWA; Tjon JML; Snijders TJF; van Lammeren D; Veelken H; Falkenburg JHF; Halkes CJM; de Wreede LC
    Front Immunol; 2024; 15():1335341. PubMed ID: 38545096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction, management, and prognosis of mixed chimerism after hematopoietic stem cell transplantation in transfusion-dependent pediatric thalassemia patients.
    Chen H; Li XY; Zhan LP; Fang JP; Huang K; Li Y; Weng WJ; Xu LH; Xu HG; Zhou DH
    Pediatr Transplant; 2020 Dec; 24(8):e13876. PubMed ID: 33098346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohematologic reconstitution in pediatric patients after T cell-depleted HLA-haploidentical stem cell transplantation for thalassemia.
    Isgrò A; Marziali M; Sodani P; Gaziev J; Erer B; Polchi P; Paciaroni K; Roveda A; De Angelis G; Gallucci C; Alfieri C; Simone MD; Zinno F; Isacchi G; Adorno G; Lanti A; Leti W; Aiuti F; Fraboni D; Andreani M; Lucarelli G
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1557-66. PubMed ID: 20546907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose donor memory T-cell infusion after TCR alpha/beta depleted unrelated and haploidentical transplantation: results of a pilot trial.
    Maschan M; Blagov S; Shelikhova L; Shekhovtsova Z; Balashov D; Starichkova J; Kurnikova E; Boyakova E; Muzalevskii Y; Kazachenok A; Trakhtman P; Osipova E; Khripkova N; Zhogov V; Novichkova G; Maschan A
    Bone Marrow Transplant; 2018 Mar; 53(3):264-273. PubMed ID: 29269793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of donor lymphocyte infusions in thalassemia patients at imminent risk of graft rejection following stem cell transplantation.
    Karasu GT; Yesilipek MA; Karauzum SB; Uygun V; Manguoglu E; Kupesiz A; Hazar V
    Pediatr Blood Cancer; 2012 Mar; 58(3):453-8. PubMed ID: 21990066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matched Family versus Alternative Donor Hematopoietic Stem Cell Transplantation for Patients with Thalassemia Major: Experience from a Tertiary Referral Center in South India.
    Swaminathan VV; Uppuluri R; Patel S; Ravichandran N; Ramanan KM; Vaidhyanathan L; Ramakrishnan B; Jayakumar I; Raj R
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1326-1331. PubMed ID: 32200123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
    Hsieh MM; Fitzhugh CD; Weitzel RP; Link ME; Coles WA; Zhao X; Rodgers GP; Powell JD; Tisdale JF
    JAMA; 2014 Jul; 312(1):48-56. PubMed ID: 25058217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia major.
    Aker M; Kapelushnik J; Pugatsch T; Naparstek E; Ben-Neria S; Yehuda O; Amar A; Nagler A; Slavin S; Or R
    J Pediatr Hematol Oncol; 1998; 20(2):145-8. PubMed ID: 9544166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BEAM-Campath Allogeneic Stem Cell Transplant for Patients with Relapsed/Refractory Lymphoma: High Incidence of Long-Term Mixed Donor-Recipient Chimerism and the Response to Donor Lymphocyte Infusions.
    Burney C; Wadhera K; Breslin P; Pearce R; Wells M; Alajangi R; Protheroe R; Marks DI; Griffin J; Robinson S
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2271-2278. PubMed ID: 32890747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors.
    Anurathapan U; Hongeng S; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Charoenkwan P; Jetsrisuparb A; Sanpakit K; Rujkijyanont P; Meekaewkunchorn A; Lektrakul Y; Iamsirirak P; Surapolchai P; Satayasai W; Sirireung S; Sruamsiri R; Wahidiyat PA; Ungkanont A; Issaragrisil S; Andersson BS
    Bone Marrow Transplant; 2016 Jun; 51(6):813-8. PubMed ID: 26878659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.
    Spitzer TR; McAfee S; Sackstein R; Colby C; Toh HC; Multani P; Saidman S; Weyouth DW; Preffer F; Poliquin C; Foley A; Cox B; Andrews D; Sachs DH; Sykes M
    Biol Blood Marrow Transplant; 2000; 6(3A):309-20. PubMed ID: 10905768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Donor Lymphocyte Infusion From Two Types of Donors on Mixed Chimerism With Secondary Graft Failure After Allogeneic Hematopoietic Stem Cell Transplantation.
    Ren RR; Ma LM; Xie YX; Tian WW; Wang T
    Transplant Cell Ther; 2022 Mar; 28(3):152.e1-152.e7. PubMed ID: 34973501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploidentical stem cell transplantation augmented by CD45RA negative lymphocytes provides rapid engraftment and excellent tolerability.
    Shook DR; Triplett BM; Eldridge PW; Kang G; Srinivasan A; Leung W
    Pediatr Blood Cancer; 2015 Apr; 62(4):666-73. PubMed ID: 25559618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor.
    Bashey A; Solomon SR
    Bone Marrow Transplant; 2014 Aug; 49(8):999-1008. PubMed ID: 24842530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.
    Dey BR; McAfee S; Colby C; Sackstein R; Saidman S; Tarbell N; Sachs DH; Sykes M; Spitzer TR
    Biol Blood Marrow Transplant; 2003 May; 9(5):320-9. PubMed ID: 12766882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of donor lymphocyte infusion for treatment of mixed donor chimerism after a reduced-intensity preparative regimen for pediatric patients with nonmalignant diseases.
    Haines HL; Bleesing JJ; Davies SM; Hornung L; Jordan MB; Marsh RA; Filipovich AH
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):288-92. PubMed ID: 25464116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor Lymphocyte Infusion-Mediated Graft-versus-Host Responses in a Preclinical Swine Model of Haploidentical Hematopoietic Cell Transplantation.
    Duran-Struuck R; Matar AJ; Crepeau RL; Teague AGS; Horner BM; Pathiraja V; Spitzer TR; Fishman JA; Bronson RT; Sachs DH; Huang CA
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):1953-1960. PubMed ID: 27543159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.